Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Acorda Therapeutics (ACOR)
Acorda Therapeutics (ACOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,205
  • Shares Outstanding, K 1,242
  • Annual Sales, $ 118,570 K
  • Annual Income, $ -65,920 K
  • 60-Month Beta 1.44
  • Price/Sales 0.15
  • Price/Cash Flow N/A
  • Price/Book 0.28
Trade ACOR with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 62.31%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.05 unch
on 02/23/24
17.28 -24.50%
on 01/24/24
-3.72 (-22.21%)
since 01/23/24
3-Month
9.60 +35.90%
on 11/27/23
18.00 -27.52%
on 01/18/24
+3.25 (+33.12%)
since 11/21/23
52-Week
8.98 +45.31%
on 05/01/23
24.20 -46.08%
on 05/08/23
-5.55 (-29.86%)
since 02/23/23

Most Recent Stories

More News
3 Biotech Stocks to Keep an Eye on in 2024

The biotechnology industry is witnessing remarkable expansion, propelled by notable advances in drug development, an increase in merger and acquisition activities, proliferation of technological innovations,...

ACOR : 13.05 (-3.36%)
EQ : 2.54 (-2.31%)
ORGO : 3.46 (+2.06%)
Moderna (MRNA) and Acorda Therapeutics (ACOR): Buy, Hold, or Sell in 2024?

The biotech industry is growing as a result of steady demand and tech advancements. Therefore, let’s assess the prospects of biotech stocks Acorda Therapeutics (ACOR) and Moderna (MRNA). Read on... ...

ACOR : 13.05 (-3.36%)
MRNA : 96.46 (-3.00%)
3 Biotech Stocks Flashing Year-End 'Buy' Signals"

Despite macroeconomic challenges, the biotech industry thrives on innovation, demand, adaptability, and technological advancements, demonstrating resilience and adaptability. So, it could be wise to invest...

ACOR : 13.05 (-3.36%)
GLPG : 36.24 (-8.28%)
ORGO : 3.46 (+2.06%)
3 Safe Biotech Stocks to Buy This Week

Given enhanced healthcare spending, the growing frequency of chronic diseases, government support, and rapid digital transformation, the biotech industry appears to have favorable prospects. Therefore,...

ACOR : 13.05 (-3.36%)
CRSP : 83.99 (-2.55%)
INVA : 15.48 (unch)
VRTX : 430.11 (+0.78%)
Acorda: Q3 Earnings Snapshot

Acorda: Q3 Earnings Snapshot

ACOR : 13.05 (-3.36%)
Acorda: Q2 Earnings Snapshot

Acorda: Q2 Earnings Snapshot

ACOR : 13.05 (-3.36%)
Time to Capitalize on These 3 Hot Biotech Stocks

The biotech industry is well-positioned for growth thanks to rising demand for quality healthcare, the prevalence of chronic diseases, and the government’s push to boost domestic biotech production and...

ACOR : 13.05 (-3.36%)
CORT : 22.45 (-2.35%)
LGND : 75.87 (+3.14%)
XBI : 94.75 (+0.64%)
3 Buy Worthy Biotech Stocks for May

The biotech industry is well-positioned to witness significant growth with government support and breakthrough developments. Therefore, biotech stocks BioNTech SE (BNTX), Acorda Therapeutics (ACOR), and...

ACOR : 13.05 (-3.36%)
BNTX : 93.97 (+0.43%)
SGIOY : 11.8800 (+0.08%)
Acorda: Q1 Earnings Snapshot

Acorda: Q1 Earnings Snapshot

ACOR : 13.05 (-3.36%)
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027

Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons,...

IMC.AX : 0.070 (-1.41%)
SILO : 1.5700 (+2.61%)
LLY : 769.54 (-0.01%)
ACOR : 13.05 (-3.36%)
TRVN : 0.5611 (-1.25%)
IMRN : 1.7600 (-2.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Acorda Therapeutics, Inc. is a biotechnology company developing and commercializing neurology therapies for Parkinson's disease, migraine and multiple sclerosis. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease and multiple sclerosis....

See More

Key Turning Points

3rd Resistance Point 13.80
2nd Resistance Point 13.65
1st Resistance Point 13.35
Last Price 13.05
1st Support Level 12.89
2nd Support Level 12.74
3rd Support Level 12.44

See More

52-Week High 24.20
Fibonacci 61.8% 18.38
Fibonacci 50% 16.59
Fibonacci 38.2% 14.79
Last Price 13.05
52-Week Low 8.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar